NF-kB promotes the release of inflammatory cytokines such IL-6 and TNF-α causing liver tissue damage and increasing NAFLD aggravation (Henkel et al. 2018; Zhang et al. 2016). This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.